Masaki Hirano
- Genetics top 10%
- Glioma Diagnosis and Treatment 15
-
- MicroRNA in disease regulation 3
-
- Neuroblastoma Research and Treatments 3
- Neurofibromatosis and Schwannoma Cases 3
-
- Meningioma and schwannoma management 7
-
- Brain Metastases and Treatment 5
-
- Epigenetics and DNA Methylation 3
- Extracellular vesicles in disease 2
Masaki Hirano
29 papers receiving 324 citations
Peers
Comparison fields: 5 of 72
- Genetics 151
- Structural Biology 6
- Cancer Research 61
- Neurology 46
- Epidemiology 82
Countries citing papers authored by Masaki Hirano
This map shows the geographic impact of Masaki Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Hirano more than expected).
Fields of papers citing papers by Masaki Hirano
This network shows the impact of papers produced by Masaki Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Hirano. The network helps show where Masaki Hirano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masaki Hirano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 10 | |
| 3 | 2021 | 15 | |
| 4 | 2021 | 20 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 37 | |
| 7 | 2020 | 9 | |
| 8 | 2019 | 4 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 4 | |
| 11 | 2019 | 40 | |
| 12 | 2018 | 6 | |
| 13 | 2018 | 12 | |
| 14 | 2018 | 13 | |
| 15 | 2017 | 5 | |
| 16 | 2017 | 8 | |
| 17 | 2017 | 13 | |
| 18 | 2016 | 12 | |
| 19 | 1991 | 35 | |
| 20 | [Histological effects of cis-platinum-peplomycin induction chemotherapy for head and neck carcinomas]. | 1985 | 2 |
About Masaki Hirano
Masaki Hirano is a scholar working on Genetics, Neurology and Cancer Research, having authored 29 papers that have together received 332 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (15 papers), Meningioma and schwannoma management (7 papers), Brain Metastases and Treatment (5 papers), Epigenetics and DNA Methylation (3 papers), Neuroblastoma Research and Treatments (3 papers), MicroRNA in disease regulation (3 papers), Neurofibromatosis and Schwannoma Cases (3 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Genetics (151 citations), Structural Biology (6 citations) and Cancer Research (61 citations). Masaki Hirano has collaborated with scholars based in Japan, Chile and Singapore. Frequent co-authors include Toshihiko Wakabayashi, Atsushi Natsume, Kosuke Aoki, Kazuya Motomura, Fumiharu Ohka, Kuniaki Tanahashi, Lushun Chalise, Tomohide Nishikawa, Junya Yamaguchi and Hiroyuki Shimizu. Their work appears in journals such as PLoS ONE, ACS Applied Materials & Interfaces and Journal of neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.